Provide transparent information quickly by Genexine

Accurate and fast delivery of key events and news of growing Genexine

Monthly News about Genexine

Genexine: Pay Attention to HyFc Platform Technology
2020.08.01

[BusinessKorea] Wielding its DNA vaccine and hyFc platform technologies, Genexine is running more clinical programs than any other domestic biotech player. The firm has announced stellar results in its clinical trials for GX-17 +Keytruda combo therapy to treat TNBC. GX-17 is showing potential to treat other kinds of cancer as well. 

http://www.businesskorea.co.kr/news/articleView.html?idxno=49891